CARDIAC TROPONIN I DETECTION DURING PREGNANCY FOR CARDIOVASCULAR DISEASE IDENTIFICATION AND RISK ASSESSMENT

摘要

The present invention provides systems and methods for determining and reporting the cardiac troponin I (cTnI) concentration in a sample from a pregnant woman (in the first, second, or third trimester) by determining whether the sample (cTnI) concentration is higher than a 99th percentile cTnI concentration from a corresponding first, second, or third trimester uncomplicated pregnancy control group, thereby determining if the pregnant woman has or is at risk of developing cardiovascular disease, such as gestational hypertension.